Holen Sie sich die Stockscreener-App
6.57
2.66%
0.17
Handel nachbörslich:
6.57
Schlusskurs vom Vortag:
$6.40
Offen:
$6.42
24-Stunden-Volumen:
263.89K
Relative Volume:
0.62
Marktkapitalisierung:
$435.97M
Einnahmen:
$555.06M
Nettoeinkommen (Verlust:
$-39.48M
KGV:
-10.95
EPS:
-0.6
Netto-Cashflow:
$29.05M
1W Leistung:
+4.95%
1M Leistung:
-1.79%
6M Leistung:
-34.50%
1J Leistung:
-11.81%
1-Tages-Spanne:
$6.33
$6.61
1-Wochen-Bereich:
$6.26
$6.61
52-Wochen-Spanne:
$6.02
$14.38
Bioventus Inc Stock (BVS) Company Profile
Firmenname
Bioventus Inc
Sektor
Branche
Telefon
(919) 474-6700
Adresse
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
Vergleichen Sie BVS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BVS
Bioventus Inc
|
6.57 | 424.69M | 555.06M | -39.48M | 29.05M | -0.60 |
|
ABT
Abbott Laboratories
|
126.54 | 218.59B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.14 | 157.13B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
403.53 | 151.59B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.94 | 118.29B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
80.00 | 44.46B | 5.69B | 4.15B | 623.10M | 6.95 |
Bioventus Inc Stock (BVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-07 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-12-17 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2023-12-07 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-08-09 | Hochstufung | Craig Hallum | Hold → Buy |
| 2022-11-22 | Herabstufung | Craig Hallum | Buy → Hold |
| 2022-11-09 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-11-09 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2022-03-15 | Eingeleitet | Craig Hallum | Buy |
| 2021-11-15 | Fortgesetzt | Morgan Stanley | Overweight |
| 2021-11-10 | Fortgesetzt | JP Morgan | Overweight |
| 2021-07-01 | Herabstufung | Goldman | Buy → Neutral |
| 2021-03-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-03-08 | Eingeleitet | Goldman | Buy |
| 2021-03-08 | Eingeleitet | JP Morgan | Overweight |
| 2021-03-08 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Bioventus Inc Aktie (BVS) Neueste Nachrichten
What makes Bioventus Inc. stock price move sharplyFree Stock Market Query - Metal.it
What drives Bioventus Inc. stock priceFree Consultation - PrintWeekIndia
What analysts say about Bioventus Inc. stockConsistent wealth multiplication - PrintWeekIndia
Bioventus Inc. Stock Analysis and ForecastUnmatched market gains - PrintWeekIndia
Why Bioventus Inc. stock attracts strong analyst attention3x Return Stock Radar - Newser
Is Bioventus Inc. a good long term investmentHigh-octane gains - jammulinksnews.com
Bioventus (NASDAQ:BVS) Cut to “Buy” at Wall Street Zen - Defense World
Cantor Fitzgerald Initiates Coverage of Bioventus (BVS) with an Overweight Rating - MSN
Bioventus (NASDAQ:BVS) Downgraded to Buy Rating by Wall Street Zen - MarketBeat
Analysts Expect Bioventus Inc. (NASDAQ:BVS) To Breakeven Soon - simplywall.st
why bioventus inc. stock attracts strong analyst attentionWeekly Big Movers - newser.com
How Bioventus Inc. stock performs during market volatilityBreakout Momentum Stocks - beatles.ru
10 Undervalued Medical Device Stocks to Buy Now - Insider Monkey
Allspring Global Investments Holdings LLC Raises Stock Holdings in Bioventus Inc. (NYSE:BVS) - Defense World
With 36% stake, Bioventus Inc. (NASDAQ:BVS) seems to have captured institutional investors' interest - Yahoo Finance
How the (BVS) price action is used to our Advantage - news.stocktradersdaily.com
Bioventus(BVS) Shares Soar 3.54% on Pipeline Progress - AInvest
Cantor Fitzgerald Initiates Coverage on Bioventus (NYSE:BVS) - Defense World
Finanzdaten der Bioventus Inc-Aktie (BVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):